Hints and tips:
...WeWork prepared for the manoeuvre last month by changing from a corporation to a limited liability company, called the We Company MC LLC....
...Chemical group Bayer is in trouble over last year’s $63bn acquisition of US rival Monsanto, whose herbicides have been linked in court cases to cancer....
...Volkswagen’s AGM comes just weeks after the chief executive of Bayer received a vote of no confidence from a majority of shareholders — a first in postwar Germany corporate history....
...to buy Travelport in $4.4bn deal (FT) Tesla CEO Elon Musk: The 60 Minutes Interview (CBS) Interserve in financial rescue talks with creditors (FT) Activist investor Elliott builds stake in Germany’s Bayer...
...fraudulent memo on CA deal risk (BBG) SoftBank in talks to invest $10bn in WeWork (FT) Natixis payments explores Ingenico takeover bid (BBG) Aviva chief pays price for muddled strategic message (FT) Bayer...
...The fee collected by Goldman is lower than the $120m brought in by Morgan Stanley for advising Monsanto in its $66bn sale to Germany’s Bayer, which was the highest advisory fee paid to an investment bank...
...In a sign that regulators in Washington are just as alive to such issues, the US Department of Justice sued Deere & Co last week to block its purchase of Monsanto’s Precision Planting LLC equipment unit,...
...Marijn Dekkers, chief executive, said: “The upward trend in our life science businesses – healthcare and cropscience – continued in the third quarter of 2012 …We remain on a successful path, and we confirm...
...Then there are all the cash-rich, growth-poor pharma companies with a proven interest in diversification, from Sanofi to Bayer....
...Potential bidders for Bausch & Lomb include Abbot Group, Merck, Sanofi, Bayer, Pfizer, and GlaxoSmithKline. News of the potential sale was first reported by Bloomberg....
...Analysts have also cautioned that Lucentis faces fresh competition from aflibercept, Regeneron and Bayer’s drug....
...We’ve engaged with the four multinational companies with seed production operations in India – Monsanto, Bayer, Syngenta and DuPont – and we’ve seen some good results across the sector.”...
...Sale of Talecris Biotherapeutics, carved out from German conglomerate Bayer, is likely to return Cerberus six times its initial investment, assuming the approvals come through as expected, according to...
...Bayer’s oral contraceptive range, including Yasmin, Yaz and Yasminelle, generated total worldwide sales last year of €1.1bn....
...Other agricultural biotech companies in the market include DuPont, Dow and Bayer CropScience, which was formed in 2001 by Bayer’s purchase of Aventis ....
...The CropScience revamp, however, will lead to special cash charges of about €330m, and writedowns of around €120m, mainly in the 2007 and 2008 results. Bayer stock fell 0.7 per cent to €39.26....
...The jump in revenues was largely due to the booking of a number of large advisory fees, including Greenhill’s work on the $20bn acquisition of Schering by Bayer, the German pharmaceuticals group....
...The US-based group will seek a deal with a major agricultural specialist, such as Syngenta or Bayer CropScience....
...Also in the pharmaceuticals sector, Bayer, the German drugs and chemicals group, said that second-phase trials showed that its stroke-treatment drug was effective and safe....
...Chemicals were also strong, with Bayer up 2.6 per cent to €26.57 after Credit Suisse First Boston raised its price target on the stock from €26 to €28....
...Olaf Toelke, Standard & Poor's analyst, said “bad peer reporting” had hurt Bayer, who said the demerger of its chemical-focused Lanxess unit on January 31 would allow Bayer to focus on high-quality products...
...Bayer, the German drugs and chemicals group, rose 2.6 per cent to €24.43 after Lehman Brothers hoisted its recommendation on the company to “overweight” from the previous “equalweight” and its fair value...
...CSFB has also advised other large companies recently, including Ispat and Bayer. The name change has not been decided but similar schemes have worked for other investment banks....
International Edition